StockNews.com assumed coverage on shares of ContraFect (NASDAQ:CFRX – Free Report) in a report published on Sunday. The firm issued a sell rating on the biotechnology company’s stock. ContraFect Price Performance Shares of NASDAQ:CFRX opened at $0.59 on Friday. The business has a fifty day simple moving average of $0.95 and a 200 day simple […]
StockNews.com started coverage on shares of ContraFect (NASDAQ:CFRX – Free Report) in a report published on Sunday morning. The brokerage issued a sell rating on the biotechnology company’s stock. ContraFect Price Performance Shares of NASDAQ CFRX opened at $0.59 on Friday. The firm’s 50-day moving average price is $0.95 and its two-hundred day moving average […]
ContraFect Co. (NASDAQ:CFRX – Get Free Report) was the target of a significant drop in short interest during the month of August. As of August 31st, there was short interest totalling 7,700 shares, a drop of 34.2% from the August 15th total of 11,700 shares. Based on an average daily volume of 571,600 shares, the […]
StockNews.com initiated coverage on shares of ContraFect (NASDAQ:CFRX – Free Report) in a research note released on Saturday morning. The firm issued a sell rating on the biotechnology company’s stock. ContraFect Price Performance NASDAQ:CFRX opened at $0.66 on Friday. ContraFect has a one year low of $0.62 and a one year high of $19.20. The […]
Research analysts at StockNews.com initiated coverage on shares of ContraFect (NASDAQ:CFRX – Get Free Report) in a research note issued on Saturday. The firm set a “sell” rating on the biotechnology company’s stock. ContraFect Stock Performance CFRX stock opened at $0.77 on Friday. ContraFect has a 52 week low of $0.69 and a 52 week […]